Q2 FY2026 EarningsQ2 FY26 results significantly exceeded consensus across all key profitability and top-line metrics. Net revenue reached $53.0M (approx. CAD 73.1M) vs. CAD 61.2M expected, driven by a 58% YoY increase fueled by international medical sales in Israel and Germany. Gross margin expanded to 54.0%, beating the 44.9% consensus by 9.10pct. Diluted EPS of $0.09 (approx. CAD 0.12) substantially outperformed the CAD 0.014 mean estimate, supported by a $20.2M foreign currency gain and disciplined cost management.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Cronos(CRON) the Revenue is 52.37 M (+55.9%), Beat estimate;the EBIT is 7.315 M (+236.8%), Beat estimate;the EPS is 0.0889 (+188.6%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.05B55.90%
0.04B28.18%
+0.01B27.72%
EBITExceed expectations
0.01B236.83%
-0.00B51.21%
+0.01B185.62%
EPSExceed expectations
0.0889188.55%
0.0099109.82%
+0.079078.73%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf